爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300015 爱尔眼科

午间休市 12-29 11:30:00

{"stockData":{"symbol":"300015","market":"SZ","secType":"STK","nameCN":"爱尔眼科","latestPrice":11.05,"timestamp":1766980872000,"preClose":11.13,"halted":0,"volume":21398661,"delay":0,"changeRate":-0.0072,"floatShares":7955000000,"shares":9325000000,"eps":0.3452,"marketStatus":"午间休市","change":-0.08,"latestTime":"12-29 11:30:00","open":11.12,"high":11.13,"low":11.05,"amount":237000000,"amplitude":0.0072,"askPrice":11.06,"askSize":762,"bidPrice":11.05,"bidSize":10665,"shortable":0,"etf":0,"ttmEps":0.3452,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766984400000},"marketStatusCode":3,"adr":0,"adjPreClose":11.13,"symbolType":"stock","openAndCloseTimeList":[[1766971800000,1766979000000],[1766984400000,1766991600000]],"highLimit":12.24,"lowLimit":10.02,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":9325396670,"isCdr":false,"pbRate":4.63,"roa":"--","peRate":32.010429,"roe":"14.32%","epsLYR":0.3847,"committee":0.504564,"marketValue":103046000000,"turnoverRate":0.0027,"status":1,"floatMarketCap":87907000000},"requestUrl":"/m/hq/s/300015","defaultTab":"news","newsList":[{"id":"2594429981","title":"爱尔眼科：公司高度重视市值管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2594429981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594429981?lang=zh_cn&edition=full","pubTime":"2025-12-26 20:52","pubTimestamp":1766753524,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科12月25日在投资者关系平台上答复投资者关心的问题。公司高度重视市值管理，践行长期主义，多次通过高管增持、股份回购等多种措施提振信心，并持续加大现金分红力度，上市以来累计现金分红及股份回购总额将达84.49亿元。后续如有进一步增持计划，公司将按照相关规定及时披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600033299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015","BK0114","LU1820825898.SGD","BK0188","LU0979878070.USD","BK0096","BK0028","BK0012","LU1146622755.USD","BK0200","LU1242518857.USD","BK0196","BK0077","BK0236","BK0113","LU1242518931.SGD"],"gpt_icon":0},{"id":"2594308662","title":"爱尔眼科9.63亿元收购39家机构部分股权，多个标的处在扭亏为盈拐点","url":"https://stock-news.laohu8.com/highlight/detail?id=2594308662","media":"视频滚动新闻","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594308662?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:37","pubTimestamp":1766673420,"startTime":"0","endTime":"0","summary":"12月24日，爱尔眼科公告将以自有资金9.63亿元收购亳州爱尔、连云港爱尔等39家机构部分股权，交易对手多为投资基金。39家标的2024年整体收入6.86亿元、净利润亏损5899.51万元，2025年1 - 9月整体收入5.88亿元、净利润2024.59万元，大多处扭亏拐点。虽部分医院亏损、净资产为负，但收购利于控制成本，未来盈利将提升。2025年前三季度，爱尔眼科营收174.84亿元、同比增7.25%，归母净利润31.15亿元、同比降9.76%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/videoroll/2025-12-25/doc-inhcztfz8678388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300015","BK0114","LU1820825898.SGD","BK0188","LU0979878070.USD","BK0096","BK0028","BK0012","LU1146622755.USD","BK0200","LU1242518857.USD","BK0196","BK0077","BK0236","BK0113","LU1242518931.SGD"],"gpt_icon":0},{"id":"2593247405","title":"爱尔眼科(300015.SZ)拟9.63亿元收购亳州爱尔、连云港爱尔等39家机构部分股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2593247405","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593247405?lang=zh_cn&edition=full","pubTime":"2025-12-24 20:38","pubTimestamp":1766579930,"startTime":"0","endTime":"0","summary":"智通财经APP讯，爱尔眼科(300015.SZ)发布公告，公司于2025年12月24日召开第七届董事会第二次会议，审议通过《关于收购亳州爱尔、连云港爱尔等39家机构部分股权的议案》，本次交易以自有资金支付，交易合计金额为9.63亿元。公司本次收购39家机构的部分股权，有利于尽快完善区域市场布局，形成规模效应，进一步深化在全国各地的“分级连锁”体系，巩固和提升公司的领先地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385632.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"爱尔眼科(300015.SZ)拟9.63亿元收购亳州爱尔、连云港爱尔等39家机构部分股权","news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1820825898.SGD","601008","BK0012","BK0114","BK0113","BK0000","LU1242518857.USD","BK0047","LU1242518931.SGD","BK0270","LU0979878070.USD","BK0236","LU1146622755.USD","BK0200","BK0028","BK0188","BK0077","300015","BK0196","BK0096"],"gpt_icon":0},{"id":"2593905994","title":"爱尔眼科：公司每年末对商誉资产进行减值测试","url":"https://stock-news.laohu8.com/highlight/detail?id=2593905994","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593905994?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:51","pubTimestamp":1766494276,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科12月22日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的净资产220亿左右，商誉87亿占公司净资产接近40%的幅度，属于危险区域范围内，如果单院利润下降或者总体大幅度下滑，请问该公司怎么应对潜在威胁？公司每年末都会按照相关准则对商誉资产进行谨慎的减值测试，存在减值迹象的计提减值准备。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300037542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1242518857.USD","BK0012","LU1242518931.SGD","BK0028","LU1820825898.SGD","BK0114","BK0188","BK0200","BK0236","LU0979878070.USD","300015","BK0113","BK0077","LU1146622755.USD","BK0196","BK0096"],"gpt_icon":0},{"id":"2593640394","title":"吉林通报不合格医疗器械 大安爱尔眼科眼部热敷贴登榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2593640394","media":"中金财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593640394?lang=zh_cn&edition=full","pubTime":"2025-12-23 14:57","pubTimestamp":1766473024,"startTime":"0","endTime":"0","summary":"中国经济网北京12月23日讯 吉林省药品监督管理局网站近期发布吉林省医疗器械质量公告 。为加强医疗器械质量监督管理，保障医疗器械产品使用安全有效，吉林省药品监督管理局在全省范围内组织开展质量抽查检验，现将本期不合格产品信息予以公告。药品监督管理部门已要求相关单位采取风险防控措施，对不合格产品依据相关法律法规进行查处。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/23/20251223711027.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/23/20251223711027.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251223/31884513.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1146622755.USD","LU1820825898.SGD","BK0188","BK0113","BK0196","BK1574","BK0236","BK1583","300015","BK0096","BK1100","BK0200","BK0028","LU1242518857.USD","BK0012","BK0114","LU1242518931.SGD","159883","BK0077","09996","LU0979878070.USD","09997","BK1222"],"gpt_icon":0},{"id":"2592264905","title":"爱尔眼科：公司高度重视市值管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2592264905","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592264905?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:51","pubTimestamp":1766062299,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)12月17日在投资者关系平台上答复投资者关心的问题。投资者提问：请问下董秘  多年来股票资金持续流出，股价持续探底，是不是公司价值投资，医疗龙头的概念，市场和股民对公司认可已经大幅度降低，公司有做市值管理或者后续有回购股票注销计划吗？爱尔眼科回复：谢谢关注。公司高度重视市值管理，持续加强市场沟通，并通过股份回购、高管增持、现金分红等多种措施体现信心，后续如有进一步回购计划，将按照相关规定及时披露。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800035375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0979878070.USD","LU1820825898.SGD","BK0200","LU1242518857.USD","BK0113","LU1242518931.SGD","LU1146622755.USD","BK0188","BK0077","BK0012","BK0196","BK0096","BK0114","300015","BK0236","BK0028"],"gpt_icon":0},{"id":"2591198418","title":"爱尔眼科：通过股份回购增强投资者获得感","url":"https://stock-news.laohu8.com/highlight/detail?id=2591198418","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591198418?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:51","pubTimestamp":1765889494,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)12月15日在投资者关系平台上答复投资者关心的问题。投资者提问：每天都在跌，每天都在创新低，理由是什么？公司股票跟大盘背道而驰，照这样跌下去，股价下个月就剩个位数的了，公司每年赚那么多钱，这个时候不拿出一部分钱回购股票，实在是寒了几十万股东的心了爱尔眼科回复：谢谢关注。公司坚持长期主义，为社会和股东持续创造价值，并通过股份回购、高管增持、现金分红等多种措施增强投资者的获得感， 后续如有进一步回购计划，公司将按规定披露信息。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600038076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1242518931.SGD","BK0200","BK0012","BK0096","LU1242518857.USD","BK0196","LU1820825898.SGD","BK0028","300015","LU0979878070.USD","BK0114","BK0077","BK0236","BK0113","BK0188","LU1146622755.USD"],"gpt_icon":0},{"id":"2591361405","title":"爱尔眼科：近视高发化、人口老龄化、生活手机化持续催生眼健康需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2591361405","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591361405?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:30","pubTimestamp":1765791040,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科12月15日在投资者关系平台上答复投资者关心的问题。请问董秘，在公司股价不断创下上市新低，为何公司董事长和高层没有增持，公司高层是最了解公司生产经营情况及将来成长性的吧？近视高发化、人口老龄化、生活手机化都在持续催生眼健康需求，公司秉承长期主义，专注于高技术医疗、高标准服务、高质量发展。后续如有相关信息，公司将及时披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500021645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0979878070.USD","BK0188","LU1242518931.SGD","BK0236","BK0028","LU1146622755.USD","BK0114","LU1820825898.SGD","BK0077","BK0200","BK0012","BK0113","BK0196","BK0096","LU1242518857.USD","300015"],"gpt_icon":0},{"id":"2591660762","title":"爱尔眼科（300015）1889.05万股限售股将于12月15日解禁，占总股本0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591660762","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591660762?lang=zh_cn&edition=full","pubTime":"2025-12-15 08:02","pubTimestamp":1765756928,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，爱尔眼科于12月15日将有1889.05万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.2%。最近一年内，该股累计解禁2624.16万股，占总股本的0.28%。本次解禁后，公司还有13.7亿股限售股份，占总股本14.69%。爱尔眼科主营业务：主要从事各类眼科疾病诊疗、手术服务与医学验光配镜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500000294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0236","BK0096","BK0012","BK0188","BK0028","BK0113","BK0114","LU1242518857.USD","LU1242518931.SGD","BK0200","300015","LU1146622755.USD","LU0979878070.USD","LU1820825898.SGD","BK0077"],"gpt_icon":0},{"id":"2590538354","title":"爱尔眼科（300015）披露2021年限制性股票激励计划部分股份解除限售提示性公告，12月10日股价下跌0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590538354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590538354?lang=zh_cn&edition=full","pubTime":"2025-12-10 22:03","pubTimestamp":1765375403,"startTime":"0","endTime":"0","summary":"截至2025年12月10日收盘，爱尔眼科报收于11.23元，较前一交易日下跌0.62%，最新总市值为1047.24亿元。近日，爱尔眼科医院集团股份有限公司发布关于2021年限制性股票激励计划首次授予部分第四个解除限售期解除限售股份上市流通的提示性公告。公告显示，本次解除限售的条件达成之日为2025年6月15日，解除限售股份上市流通时间为2025年12月15日。公司层面业绩考核达标，2024年净利润较2020年增长110.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000040802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1242518931.SGD","BK0096","BK0012","BK0236","300015","LU0979878070.USD","LU1146622755.USD","BK0114","BK0188","LU1820825898.SGD","BK0200","LU1242518857.USD","BK0196","BK0028","BK0077","BK0113"],"gpt_icon":0},{"id":"2588884625","title":"爱尔眼科：相关信息已转达","url":"https://stock-news.laohu8.com/highlight/detail?id=2588884625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588884625?lang=zh_cn&edition=full","pubTime":"2025-12-04 20:51","pubTimestamp":1764852685,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科12月03日在投资者关系平台上答复投资者关心的问题。还有，可否将本信息传达给陈邦董事长，谢谢爱尔眼科回复：谢谢建议！相关信息已转达。后续如有回购或增持计划，公司将履行信息披露义务，谢谢！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400036901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0979878070.USD","LU1820825898.SGD","BK0200","LU1242518857.USD","BK0113","LU1242518931.SGD","LU1146622755.USD","BK0188","BK0077","BK0012","BK0196","BK0096","BK0114","300015","BK0236","BK0028"],"gpt_icon":0},{"id":"2588300428","title":"爱尔眼科：与科大讯飞合作探索AI+医疗应用场景","url":"https://stock-news.laohu8.com/highlight/detail?id=2588300428","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588300428?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837034,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科12月04日在投资者关系平台上答复投资者关心的问题。2024年中，公司与科大讯飞签署战略合作框架协议，双方将发挥各自优势加强融合创新，探索应用场景，提高服务质量，惠及更多患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400022427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0231","SGXZ49509284.SGD","SGXZ81163826.USD","LU1820825898.SGD","BK0236","LU0405327148.USD","LU1242518857.USD","BK0133","LU0405327494.USD","BK0196","BK0077","BK0114","300015","002230","BK0089","LU1146622755.USD","159891","BK0028","BK0012","BK0109","BK0026","BK0200","BK0126","BK0129","BK0188","BK0113","LU0979878070.USD","LU1242518931.SGD","BK0096","BK0183"],"gpt_icon":0},{"id":"2588535910","title":"爱尔眼科：2023至2024年回购金额约5.86亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588535910","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588535910?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:52","pubTimestamp":1764679954,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科12月02日在投资者关系平台上答复投资者关心的问题。2022年公司高管增持计划总金额达2亿余元。2023至2024年，公司实施完成两期股票回购，合计成交总金额约5.86亿元，3136万余股。公司始终做好自己，持续提升基本面，以数字化赋能医疗服务，后续将根据发展情况，稳步提高分红力度增强投资者的获得感。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200036916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0200","BK0236","LU0979878070.USD","300015","LU1242518931.SGD","BK0028","BK0114","BK0077","BK0196","LU1820825898.SGD","BK0113","LU1146622755.USD","BK0012","BK0096","BK0188","LU1242518857.USD"],"gpt_icon":0},{"id":"2587756045","title":"爱尔眼科捐赠500万港元，驰援香港火灾救援","url":"https://stock-news.laohu8.com/highlight/detail?id=2587756045","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587756045?lang=zh_cn&edition=full","pubTime":"2025-11-29 10:16","pubTimestamp":1764382560,"startTime":"0","endTime":"0","summary":"　　炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　11月26日，香港新界大埔区宏福苑突发五级火警，无情烈焰吞噬家园，造成重大人员伤亡与财产损失，牵动着无数人的心。爱尔眼科联合爱眼公益基金会向受灾各方捐赠500万港币，全力支援紧急救援工作，助力受灾同胞渡过难关、重建家园。爱尔眼科将持续密切关注灾情后续进展，并与社会各界一道，心手相连、祈福平安！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-11-29/doc-infyzqqn6616722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0113","BK0188","LU1242518931.SGD","LU1146622755.USD","BK0077","LU1820825898.SGD","LU0979878070.USD","300015","BK0236","LU1242518857.USD","BK0196","BK0200","BK0012","BK0114","BK0028","BK0096"],"gpt_icon":0},{"id":"2586225253","title":"爱尔眼科：公司已采取高管增持及两次股份回购等措施","url":"https://stock-news.laohu8.com/highlight/detail?id=2586225253","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586225253?lang=zh_cn&edition=full","pubTime":"2025-11-26 20:52","pubTimestamp":1764161540,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)11月26日在投资者关系平台上答复投资者关心的问题。投资者提问：今年来各大指数和眼科医疗服务都有不错的涨幅，可公司股价不断创上市以来的新低，不见公司回购注销，也不见公司高层增持，难道高层也觉得估值过高？还是有未通报的重大问题？爱尔眼科回复：谢谢您对公司的关注。公司已采取高管增持及两次股份回购等措施，并持续加大现金分红力度，近期公告2025年中期分红预案拟派发现金7.44亿元。公司坚持高质量发展，日常经营正常。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600035814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0012","LU0979878070.USD","BK0028","300015","BK0196","BK0200","LU1242518857.USD","LU1242518931.SGD","BK0188","BK0236","BK0113","BK0096","LU1820825898.SGD","LU1146622755.USD","BK0114"],"gpt_icon":0},{"id":"1102226224","title":"爱尔眼科第三季度净利润达2830万欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102226224","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102226224?lang=zh_cn&edition=full","pubTime":"2025-11-26 01:01","pubTimestamp":1764090094,"startTime":"0","endTime":"0","summary":"11月25日讯 - 爱尔眼科股份有限公司：第三季度 EBITDA 为5940万欧元，第三季度净利润为2830万欧元，第三季度收入为2.2亿欧元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518857.USD","BK0012","LU1242518931.SGD","BK0028","LU1820825898.SGD","BK0114","BK0188","BK0200","BK0236","LU0979878070.USD","300015","BK0113","BK0077","LU1146622755.USD","BK0196","BK0096"],"gpt_icon":0},{"id":"2585464776","title":"爱尔眼科：公司已完成两期股票回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2585464776","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585464776?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:51","pubTimestamp":1763988669,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)11月24日在投资者关系平台上答复投资者关心的问题。投资者提问：公司对于接下来解禁的五千多万股如何处理，是否考虑回购注销一部分剩余的用于其他用途呢？现在股本90多亿，回购注销一些，也可以提高每股收益率爱尔眼科回复：谢谢您对公司的关注。公司已完成两期股票回购，后续如有进一步回购计划，将按照相关规则披露。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400032459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300015","BK0114","BK0196","BK0236","LU1146622755.USD","BK0113","BK0012","BK0028","LU0979878070.USD","BK0200","LU1820825898.SGD","BK0188","BK0096","LU1242518931.SGD","LU1242518857.USD"],"gpt_icon":0},{"id":"2585067148","title":"爱尔眼科：已完成两期股票回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2585067148","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585067148?lang=zh_cn&edition=full","pubTime":"2025-11-21 20:52","pubTimestamp":1763729562,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)11月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘好：建议公司不要中期分红，直接回购注销，提高每股收益，反而更有利于股东。爱尔眼科回复：谢谢您的建议！公司采取各种方式持续增强投资者获得感，目前已完成两期股票回购，后续如有进一步回购计划将按照相关规则披露。2025年中期分红预案待股东大会审议后实施。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100037042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300015","BK0114","BK0196","BK0236","LU1146622755.USD","BK0113","BK0012","BK0028","LU0979878070.USD","BK0200","LU1820825898.SGD","BK0188","BK0096","LU1242518931.SGD","LU1242518857.USD"],"gpt_icon":0},{"id":"2584418534","title":"11月20日爱尔眼科创60日新低，华宝中证医疗ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584418534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584418534?lang=zh_cn&edition=full","pubTime":"2025-11-20 15:35","pubTimestamp":1763624154,"startTime":"0","endTime":"0","summary":"证券之星消息，11月20日爱尔眼科创60日新低，收盘报11.91元，当日跌0.92%，换手率0.61%，成交量48.07万手，成交额5.76亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共45家，其中持有数量最多的公募基金为华宝基金的华宝中证医疗ETF。华宝中证医疗ETF目前规模为264.04亿元，最新净值0.3538，较上一交易日下跌0.95%，近一年上涨1.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000017765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300015","BK0114","BK0196","BK0188","BK0236","LU1146622755.USD","BK0113","BK0012","BK0028","LU0979878070.USD","BK0200","LU1820825898.SGD","512170","159828","BK0096","LU1242518931.SGD","LU1242518857.USD"],"gpt_icon":0},{"id":"2584096090","title":"爱尔眼科：开设老视门诊服务中老年人群","url":"https://stock-news.laohu8.com/highlight/detail?id=2584096090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584096090?lang=zh_cn&edition=full","pubTime":"2025-11-19 08:51","pubTimestamp":1763513514,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科11月19日在投资者关系平台上答复投资者关心的问题。公司基于先发优势，持续强化综合优势，根据眼科疾病谱的变化与时俱进，为全年龄段人群提供多层次的全眼科医疗服务。比如，为了满足人口老龄化背景下的大量新需求，公司已在多地爱尔医院开设老视门诊、糖尿病视网膜疾病门诊，并成立多学科合作的老视学组，为广大中老年人群提供适宜的视觉解决方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900005742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1242518931.SGD","BK0200","BK0012","BK0096","LU1242518857.USD","BK0196","LU1820825898.SGD","BK0028","300015","LU0979878070.USD","BK0114","BK0077","BK0236","BK0113","BK0188","LU1146622755.USD"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766980921034,"stockEarnings":[{"period":"1week","weight":-0.0202},{"period":"1month","weight":-0.0262},{"period":"3month","weight":-0.0988},{"period":"6month","weight":-0.1024},{"period":"1year","weight":-0.19},{"period":"ytd","weight":-0.1491}],"compareEarnings":[{"period":"1week","weight":0.0188},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.1575},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.1826}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"爱尔眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"344788人(较上一季度增加0.27%)","perCapita":"23073股","listingDate":"2009-10-30","address":"湖南省长沙市天心区芙蓉南路一段188号爱尔大厦","registeredCapital":"932539万元","survey":"　　爱尔眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗、手术服务与医学验光配镜服务。公司的主要产品是屈光项目、白内障项目、眼前段项目、眼后段项目、视光服务项目。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱尔眼科,300015,爱尔眼科股票,爱尔眼科股票老虎,爱尔眼科股票老虎国际,爱尔眼科行情,爱尔眼科股票行情,爱尔眼科股价,爱尔眼科股市,爱尔眼科股票价格,爱尔眼科股票交易,爱尔眼科股票购买,爱尔眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}